-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Genome Engineering for Enhanced Blood Cancer Immunotherapy (For In-person Participants)

PhD Trainee  Ticketed Session
Program: Meet the Scientist
Saturday, December 9, 2023: 8:00 AM-9:00 AM
Aqua 314 (Hilton San Diego Bayfront)
Speaker:
Carl June, MD, University of Pennsylvania
Disclosures:
June: Kite Pharma: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; AC Immune: Membership on an entity's Board of Directors or advisory committees; BluesphereBio: Membership on an entity's Board of Directors or advisory committees; Cabaletta: Membership on an entity's Board of Directors or advisory committees; Carisma: Membership on an entity's Board of Directors or advisory committees; Cartography: Membership on an entity's Board of Directors or advisory committees; Cellares: Membership on an entity's Board of Directors or advisory committees; Celldex: Membership on an entity's Board of Directors or advisory committees; Decheng: Membership on an entity's Board of Directors or advisory committees; Poseida: Membership on an entity's Board of Directors or advisory committees; Verismo: Membership on an entity's Board of Directors or advisory committees; WIRB-Copernicus: Membership on an entity's Board of Directors or advisory committees; Danaher: Membership on an entity's Board of Directors or advisory committees.
See more of: Meet the Scientist